“…We further introduce Egr2 as a molecular player, acting within Drd1 + neurons of the VLS to promote the development of drug seeking. Previous studies have showed that Egr2 is crucial for normal hindbrain development, peripheral myelination, humoral immune response, and implicated in diseases such as congenital hypomyelinating neuropathy, CharcotāMarie-Tooth disease, DejerineāSottas syndrome, as well as Schizophrenia (Boerkoel et al, 2001; De and Turman, Jr., 2005; Li et al, 2019; Morita et al, 2016; Okamura et al, 2015; Svaren and Meijer, 2008; Topilko et al, 1994; Warner, 1999; Warner et al, 1998; Wilkinson, 1995; Yamada et al, 2007). In the central nervous system, Egr2 has been shown to be induced by seizure activity, kainic acid injection, following LTP-inducing stimuli in hippocampal neurons, as well as following administration of several groups of drugs such as methamphetamine, cocaine, heroin, and alcohol (Gao et al, 2017a; Gass et al, 1994; Imperio et al, 2018; LĆ³pez-LĆ³pez et al, 2017; Mataga et al, 2001; Rakhade et al, 2007; Saint-Preux et al, 2013; Worley et al, 1993).…”